The potential of neurofilaments analysis using dry-blood and plasma spots

Vittoria Lombardi(Queen Mary University of London), Andrea Malaspina(Queen Mary University of London)

Scientific Reports

January 9, 2020

10.1038/s41598-019-54310-y

Cited by 28

Related Papers

TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A

|Nature|2022|510

Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia

|Cell Reports|2019|333

Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS

|Neurology|2020|201

Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases

|Brain|2021|116

Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism

|eLife|2018|87